Formosan Union Chemical Corp. (TPE:1709)
Taiwan · Delayed Price · Currency is TWD 18.20
+0.15 (0.83%)
At close: Mar 27, 2026
Formosan Union Chemical Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,009 | 10,304 | 9,432 | 10,571 | 9,199 | |
Revenue Growth (YoY) | -12.57% | 9.25% | -10.77% | 14.92% | 8.46% |
Cost of Revenue | 7,668 | 8,833 | 8,277 | 8,623 | 7,061 |
Gross Profit | 1,342 | 1,472 | 1,156 | 1,948 | 2,138 |
Selling, General & Admin | 640.98 | 778.2 | 660.7 | 848.98 | 851.3 |
Research & Development | 71.44 | 71.41 | 61.6 | 71.72 | 69.29 |
Other Operating Expenses | -2.16 | 1.88 | -0.26 | -0.9 | -0.75 |
Operating Expenses | 710.25 | 851.49 | 722 | 919.73 | 919.07 |
Operating Income | 631.32 | 620.13 | 433.7 | 1,029 | 1,219 |
Interest Expense | -37.39 | -45.25 | -47.24 | -33.21 | -22.06 |
Interest & Investment Income | 3.85 | 80.08 | 54.01 | 40.38 | 23.31 |
Earnings From Equity Investments | -12.79 | -5.25 | -2.42 | 37.23 | 58.45 |
Currency Exchange Gain (Loss) | - | 68.51 | 16.25 | 136.32 | -10.94 |
Other Non Operating Income (Expenses) | 154.32 | 31.73 | 9.42 | 19.86 | 18.1 |
EBT Excluding Unusual Items | 739.31 | 749.95 | 463.72 | 1,229 | 1,286 |
Impairment of Goodwill | - | - | - | - | -2.9 |
Gain (Loss) on Sale of Investments | - | 137.76 | 31.54 | 106.13 | 19.38 |
Gain (Loss) on Sale of Assets | - | 0.21 | 0.19 | 6.43 | 55.18 |
Asset Writedown | - | - | - | - | -347.13 |
Pretax Income | 739.31 | 887.93 | 495.45 | 1,342 | 1,010 |
Income Tax Expense | 153.17 | 155.22 | 83.73 | 260.58 | 91.02 |
Earnings From Continuing Operations | 586.14 | 732.71 | 411.72 | 1,081 | 919.06 |
Minority Interest in Earnings | 2.31 | 0.87 | 6.47 | 3.32 | 28.53 |
Net Income | 588.45 | 733.58 | 418.19 | 1,085 | 947.59 |
Net Income to Common | 588.45 | 733.58 | 418.19 | 1,085 | 947.59 |
Net Income Growth | -19.78% | 75.42% | -61.44% | 14.46% | 70.80% |
Shares Outstanding (Basic) | 478 | 477 | 477 | 477 | 477 |
Shares Outstanding (Diluted) | 478 | 478 | 478 | 479 | 478 |
Shares Change (YoY) | 0.03% | 0.07% | -0.18% | 0.07% | 0.02% |
EPS (Basic) | 1.23 | 1.54 | 0.88 | 2.27 | 1.99 |
EPS (Diluted) | 1.23 | 1.53 | 0.88 | 2.27 | 1.98 |
EPS Growth | -19.61% | 74.52% | -61.38% | 14.65% | 70.69% |
Free Cash Flow | 499.46 | 686.22 | 737.96 | 1,041 | 497.43 |
Free Cash Flow Per Share | 1.04 | 1.44 | 1.54 | 2.17 | 1.04 |
Dividend Per Share | - | 0.800 | 0.600 | 1.800 | 1.500 |
Dividend Growth | - | 33.33% | -66.67% | 20.00% | 25.00% |
Gross Margin | 14.89% | 14.28% | 12.25% | 18.43% | 23.24% |
Operating Margin | 7.01% | 6.02% | 4.60% | 9.73% | 13.25% |
Profit Margin | 6.53% | 7.12% | 4.43% | 10.26% | 10.30% |
Free Cash Flow Margin | 5.54% | 6.66% | 7.82% | 9.85% | 5.41% |
EBITDA | 888.7 | 829.22 | 647.8 | 1,249 | 1,458 |
EBITDA Margin | 9.86% | 8.05% | 6.87% | 11.81% | 15.85% |
D&A For EBITDA | 257.38 | 209.09 | 214.1 | 220.05 | 239.47 |
EBIT | 631.32 | 620.13 | 433.7 | 1,029 | 1,219 |
EBIT Margin | 7.01% | 6.02% | 4.60% | 9.73% | 13.25% |
Effective Tax Rate | 20.72% | 17.48% | 16.90% | 19.42% | 9.01% |
Revenue as Reported | 9,009 | - | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.